ROVAQ Ventures

Founder Christopher Greenwell runs the firm. He is also the principal of The Greenwell Firm, a law practice headquartered at the same Jefferson City, Missouri address. The dual legal-investment structure centralizes all decision-making with Greenwell personally, a model typical of single-principal investment offices in the Midwest. No additional investment committee members or partners have been publicly identified.

The firm sources primarily through the St. Louis innovation ecosystem, co-investing alongside BioGenerator Ventures and the Danforth Technology Company. Greenwell's concurrent legal practice provides a secondary sourcing channel—law firm clients engaged in company formation or intellectual property work can convert to investment opportunities. This proximity to university and research-institution spinouts, particularly from the Donald Danforth Plant Science Center, gives ROVAQ access to deal flow that bypasses traditional venture networks.

Confirmed sector exposure includes biotechnology and agricultural technology, driven by the firm's Danforth Center relationships. The Immunophotonics investment adds immuno-oncology to the list. Altss research also tags enterprise software as a potential sector interest, though no specific software portfolio company has been identified in public filings. The firm self-describes as a generalist vehicle, implying additional undisclosed sector activity.